Skip to main content
Equibles

Jeffrey S. Heier

Ocular Therapeutix, Inc (OCUL)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey S. Heier

Ocular Therapeutix, Inc reported in an 8-K filed February 22, 2024 that Jeffrey S. Heier was appointed Chief Scientific Officer, effective February 21, 2024. Ocular Therapeutix, Inc reported in an 8-K filed February 22, 2024 that Jeffrey S. Heier resigned as Board, effective February 21, 2024.

“On February 21, 2024, the Company entered into an employment agreement with Jeffrey S. Heier, M.D. (the "Heier Agreement"), under which Dr. Heier agreed to serve as Chief Scientific Officer of the Company on a part-time basis, working 50% of a full-time schedule.”
Ocular Therapeutix, Inc Form 8-K, filed February 22, 2024 · Read the filing
“Dr. Heier also resigned from the Board, effective February 21, 2024.”
Ocular Therapeutix, Inc Form 8-K, filed February 22, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Ocular Therapeutix, Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.